Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Leukemia × enasidenib × Clear all

Phase

Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1 Leukemia, Myeloid 1 Leukemia 1

Interventions

Cytarabine 59 Cyclophosphamide 39 Methotrexate 35 Etoposide 30 Daunorubicin 30 Vincristine 26 Mercaptopurine 24 Idarubicin 21 Dexamethasone 20 Radiotherapy 19 Asparaginase 18 Thioguanine 17 Doxorubicin 17 pegaspargase 15 Prednisone 14 Peripheral Blood Stem Cell Transplantation 13 Mitoxantrone 13 Imatinib Mesylate 13 Busulfan 13 fludarabine phosphate 10 Filgrastim 10 Hydrocortisone 8 Cyclosporine 8 Prednisolone 7 Leucovorin 7 Hydroxyurea 7 nilotinib 6 Tretinoin 6 Rituximab 6 Interferon-alpha 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02577406 2025-05-18

IDHENTIFY

Celgene

Phase 3 Completed

319 enrolled 29 charts

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡